[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Banco Vida, Custom Nutraceuticals and Wintac Limited.[ Price : $8.95]
A new FDA study of 252 difficult-to-make prescription drugs finds that U.S.-marketed products consistently meet quality standards ...[ Price : $8.95]
FDA says it is delaying collection of new drug manufacturing data to help it track potential drug shortages until an electronic da...[ Price : $8.95]
FDA issues a priority review voucher to Genentech for gaining approval of a rare pediatric disease product application Evrysdi (r...[ Price : $8.95]
Federal Register notice: FDA issues a final rule to remove the specified test for detecting the presence of Mycoplasma for live vi...[ Price : $8.95]
In a swirl of Trumpian controversy, FDA issues an emergency use authorization for Covid-19 convalescent plasma and its use in trea...[ Price : $8.95]
FDA awards HelixBind a breakthrough device designation for its RaPID/BSI, a direct-from-blood platform for identifying and charact...[ Price : $8.95]
FDA issues Tricida a complete response letter on its NDA for veverimer, a non-absorbed, orally-administered polymer designed to tr...